Ketamine Infusion for Neuropathic Pain in Brachial Plexus Injuries

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Brachial Plexus Injury
Interventions
DRUG

Ketamine Infustion

Intravenous infusion at 0.5 mg/kg/hr from induction to emergence from anesthesia during the subject's brachial plexus reconstruction surgery. In addition, subjects will receive postoperative ketamine infusion of 0.1-0.3 mg/kg/hr for 24 hours titrated to side effects while patients are admitted to the hospital following surgery.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04933149 - Ketamine Infusion for Neuropathic Pain in Brachial Plexus Injuries | Biotech Hunter | Biotech Hunter